Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BML-210

HDAC inhibitor
 
BML-GR330-0001 1 mg 83.00 USD
 
BML-GR330-0005 5 mg 284.00 USD
Do you need bulk/larger quantities?
 
HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC50=5-10µM).

Product Specification

Formula:C20H25N3O2
 
MW:339.4
 
CAS:537034-17-6
 
Purity:≥98% (TLC)
 
Appearance:Tan solid.
 
Solubility:Soluble in DMSO (25mg/ml) or 100% ethanol (10mg/ml, warm)
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
bml-gr330
Please mouse over
bml-gr330

Product Literature References

Herman et al.; Nature Chem. Biol. 10, 551 (2006),
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines: J. Savickiene et al.; Eur J Pharmacol 549, 9 (2006), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
HDAC
By biological activity:
HDAC Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Epigenetics
Epigenetics
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,